Stichworte
Endokrinologie ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

798 Suchergebnisse.

Eligibility Type-2 Diabetes NCT01264523

- 28.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Nutritional Intervention With Moderately High-protein, Low-glycemic Load Products in Type-2 Diabetes Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01264523

Eligibility Type II Diabetes NCT01782092

- 28.01.19 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Activator and Type II Diabetics; ODM derived from: https://clinicaltrials.gov/show/NCT01782092

Eligibility Type II Diabetes Mellitus NCT01648244

- 28.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01648244

Eligibility Type 2 Diabetic Nephropathy NCT01488877

- 28.01.19 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy; ODM derived from: https://clinicaltrials.gov/show/NCT01488877

Eligibility Type 2 Diabetes NCT02386982

- 28.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02386982

Eligibility Type 2 Diabetes NCT02374788

- 27.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Sophia Step Study - a Behaviour Change Program on Physical Activity in Persons With Pre- and Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02374788

Eligibility Type 2 Diabetes NCT02288273

- 27.01.19 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02288273

Eligibility Type 2 Diabetes NCT02236962

- 27.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT02236962

Eligibility Type 2 Diabetes NCT02021695

- 27.01.19 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
DNA Methylation and Gene Expression in Qataris With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02021695

Eligibility Type 2 Diabetes NCT01920256

- 27.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Provider-Initiated Regular Remote Interventions for Optimal Type 2 Diabetes Care; ODM derived from: https://clinicaltrials.gov/show/NCT01920256

Eligibility Type 2 Diabetes NCT01870141

- 27.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Psychological Distress and Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01870141

Eligibility Type 2 Diabetes NCT01785771

- 27.01.19 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c; ODM derived from: https://clinicaltrials.gov/show/NCT01785771